Tripelennamine

曲吡那敏

Report date: 2025/01/21 09:39:47
NME

Base Information

Drug NameTripelennamine
Drug Alias Nametripelennaminum曲吡那敏盐酸盐tripelenamina盐酸苄吡二胺吡苄明 +[10
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine receptor antagonists
TargetsHistamine receptor
Therapy Area/IndicationsHypersensitivityUrticariaEczema +[7
Global Approved IndicationsHypersensitivityUrticariaEczema +[7
Approved Indications in ChinaHypersensitivityUrticariaEczema +[7
Original Approved Country/TerritoryCanada
Original Approved Date1947/12/31
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active IndicationsHypersensitivityUrticariaEczema +[7
Inactive IndicationsN/A

Other Information

ATC CodeD04AA04R06AC04